Lilly CEO Bets on NYC for R&D

Posted by: Arlene Weintraub on July 22, 2009

Lechleiter.jpg
On July 22, Eli Lilly CEO John Lechleiter announced that his company would be the anchor tenant at New York City’s brand new biotech research center, called East River Science Park. Will this help the drug giant speed up R&D? Lechleiter hopes it will. Read more on BW’s Managing Forward blog.

 

About

How can you manage smarter? Bloomberg Businessweek contributors synthesize insights from the brightest business thinkers, critique the latest management trends, and comment on leaders in the news.

BW Mall - Sponsored Links

Buy a link now!